| # | Drug | Count |
|---|---|---|
| 0 | DURVALUMAB | 7 |
| 1 | CISPLATIN | 6 |
| 2 | TACROLIMUS | 6 |
| 3 | GEMCITABINE HYDROCHLORIDE | 5 |
| 4 | MYCOPHENOLATE MOFETIL | 3 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 3 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 7 | TACROLIMUS OINTMENT 0.1% | 3 |
| 8 | FUROSEMIDE | 2 |
| 9 | GEMCITABINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DURVALUMAB | 7 | 0.0003 |
| 1 | ALOGLIPTIN | 1 | 0.0003 |
| 2 | OLOPATADINE HYDROCHLORIDE OPHTHALMIC | 1 | 0.0002 |
| 3 | OLOPATADINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | VONOPRAZAN FUMARATE | 1 | 0.0001 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 6 | LUBIPROSTONE | 1 | 0.0001 |
| 7 | GEMCITABINE HYDROCHLORIDE | 5 | 0.0001 |
| 8 | ITRACONAZOLE | 1 | 0.0001 |
| 9 | PEGFILGRASTIM | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 7 |
| 1 | Platinum-based Drug [EPC] | 6 |
| 2 | Corticosteroid [EPC] | 5 |
| 3 | Proton Pump Inhibitor [EPC] | 3 |
| 4 | Benzodiazepine [EPC] | 2 |
| 5 | Loop Diuretic [EPC] | 2 |
| 6 | Aldosterone Antagonist [EPC] | 1 |
| 7 | Aromatic Amino Acid [EPC] | 1 |
| 8 | Atypical Antipsychotic [EPC] | 1 |
| 9 | Azole Antifungal [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 5 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 6 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 8 | Muscle Relaxant [EPC] | 1 | 0.0000 |
| 9 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |